🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Beta Bionics, Inc.

BBNX Healthcare
$20.52 $-0.99 (-4.60%)
Market Cap: $1.08 B
Gurus Holding
5
Popularity Rank
#2005
% of Shares Held
6.28%
Net Activity (Q2 2026)
-$3.21 M

Guru Ownership Trend

Guru Analysis for Beta Bionics, Inc. (BBNX)

Beta Bionics, Inc. (BBNX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $67.8 M.

Top institutional holders include Steven Cohen and Robert Bruce.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $3.21 M net outflow during the quarter.

Recent activity highlights Cliff Asness who increased their stake by 411.7%. Conversely, Paul Tudor Jones reduced exposure by 70.7%.

Key Holders

Top 5 by Value

Recent Activity Breakdown (Q2 2026)

+$5.87 M
Total Buy Value
New Buys 1
Additions 2
-$9.08 M
Total Sell Value
Reductions 2
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
3
Net Buyers
3

FAQs for Beta Bionics, Inc. (BBNX)

Major holders include Steven Cohen ($35.33 M), Robert Bruce ($10.43 M), Cliff Asness ($4.83 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 3.3 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $3.21 M, with 3 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited BBNX. The total reported sell value was $9.08 M.

Yes, 1 managers opened new positions in BBNX, and 2 increased their existing holdings. The total reported buy value was $5.87 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.04% Reduce -10.7% 2,254,683 $35.33 M Q2 2026
2.82% Add 20.9% 665,700 $10.43 M Q2 2026
0.00% Add 411.7% 308,468 $4.83 M Q2 2026
0.00% Reduce -70.7% 63,809 $999,887 Q2 2026
0.00% New Buy 11,300 $177,071 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form